Anti-thymocyte Globulin and Cyclosporine as First-Line Therapy in Treating Patients With Severe Aplastic Anemia

Clinical trial NCT01231841 · COMPLETED

Trial details

NCT number: NCT01231841
Sponsor: The Cleveland Clinic
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Aplastic Anemia

Start date: 2005-03-01
Primary completion: 2010-12-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.